ANGIOMAX RTU FDA approval date

The FDA approved ANGIOMAX RTU on 25 Jul 2019.

FDA approval date
25 Jul 2019

Drug identity has not yet been verified against registry records

Also recorded as BIVALIRUDIN

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-07-25DayANGIOMAX RTUFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211215", "applicant_as_listed_by_fda": "MAIA PHARMS INC", "brand_names": ["ANGIOMAX RTU"], "active_ingredients": ["BIVALIRUDIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190725", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026